​

REGENXBIO (RGNX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

REGENXBIO Revenue Highlights

Latest Revenue (Y)

$170.44M

Latest Revenue (Q)

$29.73M

Main Segment (Y)

License and Service

REGENXBIO Revenue by Period

REGENXBIO Revenue by Year

DateRevenueChange
2025-12-31$170.44M104.54%
2024-12-31$83.33M-7.66%
2023-12-31$90.24M-19.94%
2022-12-31$112.72M-76.03%
2021-12-31$470.35M204.30%
2020-12-31$154.57M338.70%
2019-12-31$35.23M-83.88%
2018-12-31$218.50M2002.42%
2017-12-31$10.39M126.48%
2016-12-31$4.59M-39.52%
2015-12-31$7.59M23.99%
2014-12-31$6.12M0.54%
2013-12-31$6.09M-

REGENXBIO generated $170.44M in revenue during NA 2025, up 104.54% compared to the previous quarter, and up 110.27% compared to the same period a year ago.

REGENXBIO Revenue by Quarter

DateRevenueChange
2025-09-30$29.73M39.21%
2025-06-30$21.36M-76.00%
2025-03-31$89.01M319.59%
2024-12-31$21.21M-12.33%
2024-09-30$24.20M8.53%
2024-06-30$22.30M42.72%
2024-03-31$15.62M-29.67%
2023-12-31$22.21M-23.18%
2023-09-30$28.91M44.74%
2023-06-30$19.98M4.38%
2023-03-31$19.14M-38.94%
2022-12-31$31.34M18.23%
2022-09-30$26.51M-18.80%
2022-06-30$32.65M46.95%
2022-03-31$22.22M-94.43%
2021-12-31$398.65M1195.47%
2021-09-30$30.77M39.66%
2021-06-30$22.04M16.69%
2021-03-31$18.88M-11.94%
2020-12-31$21.45M-78.32%
2020-09-30$98.91M497.08%
2020-06-30$16.57M-6.11%
2020-03-31$17.64M49.93%
2019-12-31$11.77M-19.95%
2019-09-30$14.70M86.52%
2019-06-30$7.88M791.52%
2019-03-31$884.00K-97.83%
2018-12-31$40.78M668.51%
2018-09-30$5.31M-86.75%
2018-06-30$40.03M-69.76%
2018-03-31$132.39M6389.75%
2017-12-31$2.04M52.69%
2017-09-30$1.34M-79.64%
2017-06-30$6.56M1342.20%
2017-03-31$455.00K-73.17%
2016-12-31$1.70M1256.80%
2016-09-30$125.00K-94.74%
2016-06-30$2.38M504.33%
2016-03-31$393.00K-91.16%
2015-12-31$4.45M290.18%
2015-09-30$1.14M-16.36%
2015-06-30$1.36M111.65%
2015-03-31$644.00K-43.90%
2014-12-31$1.15M137.68%
2014-09-30$483.00K-

REGENXBIO generated $29.73M in revenue during Q3 2025, up 39.21% compared to the previous quarter, and up 133.36% compared to the same period a year ago.

REGENXBIO Revenue Breakdown

REGENXBIO Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Service$14.17M----
License and Service$156.27M$83.33M$90.24M$112.72M-
License And Service----$470.35M

REGENXBIO's latest annual revenue breakdown by segment (product or service), as of Dec 25: License and Service (91.68%), and Service (8.32%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
License and Service$27.15M$23.61M$18.46M$87.05M$21.21M$24.20M$22.30M$15.62M$70.27M$19.98M$31.34M---------
Service$3.19M$6.13M$2.89M$1.96M----------------
License And Service----------$19.14M$26.51M$32.65M$22.22M$398.65M$30.77M$22.04M$18.88M--
Zolgensma Royalties-------------------$20.91M
License--------------------

REGENXBIO's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: License and Service (89.49%), and Service (10.51%).

REGENXBIO Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RGNXREGENXBIO$170.44M$29.73M
GOSSGossamer Bio$114.70M$13.29M
VSTMVerastem$30.91M$11.24M
PRTAProthena$9.68M$2.42M
ABSIAbsci$4.53M$378.00K
CRVSCorvus Pharmaceuticals--
VTYXVentyx Biosciences--
FDMT4D Molecular Therapeutics--
KALVKalVista Pharmaceuticals-$13.69M
MLTXMoonLake Immunotherapeutics--
OLMAOlema Pharmaceuticals--

RGNX Revenue FAQ

What is REGENXBIO’s yearly revenue?

REGENXBIO's yearly revenue for 2025 was $170.44M, representing an increase of 104.54% compared to 2024. The company's yearly revenue for 2024 was $83.33M, representing a decrease of -7.66% compared to 2023. RGNX's yearly revenue for 2023 was $90.24M, representing a decrease of -19.94% compared to 2022.

What is REGENXBIO’s quarterly revenue?

REGENXBIO's quarterly revenue for Q3 2025 was $29.73M, a 39.21% increase from the previous quarter (Q2 2025), and a 22.88% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $21.36M, a -76.00% decrease from the previous quarter (Q1 2025), and a -4.20% decrease year-over-year (Q2 2024). RGNX's quarterly revenue for Q1 2025 was $89.01M, a 319.59% increase from the previous quarter (Q4 2024), and a 469.79% increase year-over-year (Q1 2024).

What is REGENXBIO’s revenue growth rate?

REGENXBIO's revenue growth rate for the last 3 years (2023-2025) was 88.87%, and for the last 5 years (2021-2025) was -63.76%.

What are REGENXBIO’s revenue streams?

REGENXBIO's revenue streams in c 25 are Service, and License and Service. Service generated $14.17M in revenue, accounting 8.32% of the company's total revenue License and Service generated $156.27M in revenue, accounting 91.68% of the company's total revenue, up 87.53% year-over-year.

What is REGENXBIO’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of REGENXBIO was License and Service. This segment made a revenue of $156.27M, representing 91.68% of the company's total revenue.